QJBIOCH(SH:600796)2023-10-26 16:00Financial Performance - The company's operating revenue for Q3 2023 was CNY 460,944,260.59, a decrease of 0.86% compared to the same period last year[4]. - The net profit attributable to shareholders for Q3 2023 was CNY 55,134,983.62, an increase of 8.29% year-on-year[4]. - The basic earnings per share for Q3 2023 was CNY 0.06, unchanged from the previous quarter[5]. - Total revenue for the first three quarters of 2023 was CNY 1,328,333,633.25, a slight decrease from CNY 1,344,332,168.60 in the same period of 2022, representing a decline of approximately 1.2%[16]. - Net profit for Q3 2023 was CNY 127,157,866.81, compared to CNY 121,892,457.90 in Q3 2022, reflecting an increase of approximately 4.2%[18]. - The total comprehensive income for the third quarter of 2023 was CNY 127,157,866.81, compared to CNY 121,892,457.90 in the same period of 2022, representing an increase of approximately 4.2%[19]. - Basic and diluted earnings per share for Q3 2023 were both CNY 0.16, up from CNY 0.15 in Q3 2022, indicating a growth of 6.67%[19]. Cash Flow and Investments - The net cash flow from operating activities for the year-to-date period decreased by 34.22% to CNY 116,517,573.71[5]. - Cash inflow from operating activities for the first three quarters of 2023 was CNY 1,391,359,040.03, down from CNY 1,637,981,920.72 in the same period of 2022, a decrease of about 14.99%[22]. - The net cash flow from operating activities for the first three quarters of 2023 was CNY 116,517,573.71, compared to CNY 177,145,214.07 in 2022, reflecting a decline of approximately 34.2%[22]. - Cash outflow from investing activities in the first three quarters of 2023 was CNY 136,878,157.16, compared to CNY 208,977,353.15 in the same period of 2022, a decrease of about 34.6%[22]. - The net cash flow from financing activities for the first three quarters of 2023 was -CNY 200,448,190.99, compared to -CNY 182,147,043.60 in 2022, indicating a worsening of approximately 10.5%[23]. - The ending cash and cash equivalents balance as of September 30, 2023, was CNY 679,890,637.44, down from CNY 951,721,774.50 at the end of Q3 2022, a decrease of about 28.5%[23]. - The company received CNY 37,858,326.89 in investment income during the first three quarters of 2023, compared to CNY 34,140,197.47 in the same period of 2022, an increase of approximately 8.0%[22]. Assets and Liabilities - Total assets as of September 30, 2023, were CNY 6,539,166,988.75, a decrease of 2.36% from the end of the previous year[5]. - The company's total assets as of Q3 2023 amounted to CNY 6,539,166,988.75, a decrease from CNY 6,696,905,336.93 in the previous year, representing a decline of about 2.4%[16]. - Total liabilities for Q3 2023 were CNY 3,097,174,425.41, down from CNY 3,294,827,608.70 in Q3 2022, indicating a decrease of approximately 6.0%[15]. - The company reported a decrease in accounts receivable from CNY 589,958,020.53 in Q3 2022 to CNY 478,996,444.24 in Q3 2023, a reduction of approximately 18.8%[15]. - The company's cash and cash equivalents decreased to CNY 93,624,236.55 from CNY 44,334,545.37 year-over-year, showing an increase of about 111.1%[14]. - Long-term equity investments decreased to CNY 464,476,548.12 from CNY 508,029,571.35, reflecting a decline of approximately 8.6%[14]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 29,176[10]. - The top shareholder, Haining Water Investment Group Co., Ltd., holds 44.98% of the shares[10]. - The company reported a total equity attributable to shareholders of CNY 3,066,952,141.94, an increase of 1.74% compared to the end of the previous year[5]. - The total equity attributable to shareholders of the parent company increased to CNY 3,066,952,141.94 from CNY 3,014,592,194.05, representing an increase of about 1.7%[16]. Research and Development - Research and development expenses for Q3 2023 were CNY 22,226,502.88, slightly down from CNY 22,459,678.91 in Q3 2022, indicating a decrease of about 1.0%[17]. - The company did not report any significant new product developments or market expansion strategies during the quarter[12]. Employee Compensation - The company paid CNY 247,678,951.64 to employees in the first three quarters of 2023, an increase from CNY 191,754,616.07 in the same period of 2022, reflecting a growth of approximately 29.3%[22].